Inscription Capital’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Buy
4,598
+800
+21% +$64.2K 0.03% 466
2026
Q1
$318K Buy
3,798
+552
+17% +$41.6K 0.03% 474
2025
Q4
$218K Sell
3,246
-4,701
-59% -$304K 0.02% 584
2025
Q3
$537K Buy
7,947
+4,680
+143% +$339K 0.06% 334
2025
Q2
$243K Buy
+3,267
New +$218K 0.04% 420
2022
Q3
Sell
-100,681
Closed -$5.45M 211
2022
Q2
$5.45M Buy
+100,681
New +$5.84M 0.98% 19
2021
Q3
Sell
-11,734
Closed -$520K 244
2021
Q2
$520K Buy
+11,734
New +$542K 0.06% 194

Other funds holding CTVA

Inscription Capital's CTVA Position: Q2 2026 in Review

Inscription Capital increased its Corteva (CTVA) stake by 21% in Q2 2026, buying an estimated $64.2K and bringing the position to 4,598 shares worth $389K. The position accounts for 0.03% of the portfolio, ranked #466.

Inscription Capital first reported a position in CTVA in Q2 2021 and has held it in 7 quarters since. The position peaked at $5.45M in Q2 2022. 1,487 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Inscription Capital held 4,598 shares of Corteva worth $389K as of Q2 2026.
  • Inscription Capital bought 800 Corteva shares in Q2 2026, an estimated $64.2K.
  • Corteva made up 0.03% of Inscription Capital's portfolio in Q2 2026, its #466 holding.
  • Inscription Capital first reported a position in Corteva in Q2 2021 and has held it in 7 quarters since.
  • Inscription Capital's Corteva position peaked at $5.45M in Q2 2022.
  • 1,487 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Inscription Capital's 13F filing for Q2 2026, filed 13 Aug 2026.